Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the western
world with prevalence of 20–33%. NAFLD comprises a pathological spectrum. Nonalcoholic …

Liver cirrhosis (LC) is a chronic illness caused by inflammatory responses and progressive
fibrosis. Globally, the most common causes of chronic liver disease include persistent …

Lemon (Citrus limon) contains various bioactive flavonoids and prevents obesity and obesity-
associated metabolic diseases. We focused on eriocitrin (eriodictyol 7-rutinoside), a …

AIM: To evaluate the correlation between nonalcoholic fatty liver disease (NAFLD) and
microvascular complications in type 2 diabetes mellitus (T2DM). METHODS: Data were …

Objective. Hepatic oxidative stress plays a key role in the development of non-alcoholic
steatohepatitis (NASH). However, the protective effects of antioxidants on NASH are largely …

Introduction Obesity is a risk factor of nonalcoholic fatty liver disease. Although the standard
therapy for obesity involves physical exercise, well-planned studies of the changes in liver …

AIM: To explore the mechanism of action of gypenosides (GPs) on type 2 diabetes mellitus
and non-alcoholic fatty liver disease (T2DM-NAFLD) in rats. METHODS: Sixty rats were …

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of
pediatric liver disease. Its prevalence is related to the growing epidemic in childhood obesity …

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic
disorder, which poses a significant health burden in the western countries. As the epidemic …

Natural products and medicinal herbs have been used to treat various human diseases by
regulating cellular functions and metabolic pathways. Angelica gigas NAKAI (AG) helps …